Levin Hafa from GUF presented the advances of BRIGHTER Project at the second edition of the “EMBL-IBEC Conference on Engineering Multicellular Systems”, recently held in Barcelona.
Last 8th -10th of June Barcelona brought together renowned international researchers in fields focusing on how the engineering of multicellular living systems is driving our understanding of tissue and organ function. The “EMBL-IBEC Conference on Engineering Multicellular Systems” was centered in applications for disease modelling, drug screening, and tissue engineering.
Several talks and posters showed recent breakthroughs in stem cell biology, organ-on-chip assays, 3D bioprinting and cell mechanobiology, emphasizing in how strongly these technologies can influence our ability to design and assemble multicellular living systems, from organoids to embryos, and to impact in the medicine of the future.
In this context, Levin Hafa from GUF presented two posters about BRIGHTER project.
The first poster, signed by all partners of the project, summarized the objectives and results obtained in the project up to date. Levin presented the novel BRIGHTER’s bioprinting technique, which produces millimeter-sized objects in less than 3 minutes, using a digitally scanned light sheet. He also emphasized in the objective od producing human skin that will offer an alternative to animal testing for both pharmaceutical and cosmetics industries.
Additionally, he presented another poster about the democratization of the stereolithography 3D bioprinting: modelling the liver cancer microenvironment using a commercially available 3D printer, a work carried out at GUF by Louise Breideband. This work showed how researchers used a commercially available consumer stereolithographic 3D printer and modified it to a functioning 3D bioprinter. As a proof of concept, they were able to bio-print liver cholangiocarcinoma organoids.